224 related articles for article (PubMed ID: 34798487)
1. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects.
Le TT; Di Vincenzo JD; Teopiz KM; Lee Y; Cha DS; Lui LMW; Rodrigues NB; Ho RC; Cao B; Lin K; Nasri F; Gill H; Lipsitz O; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
Psychiatry Res; 2021 Dec; 306():114231. PubMed ID: 34798487
[TBL] [Abstract][Full Text] [Related]
2. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
[TBL] [Abstract][Full Text] [Related]
3. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
4. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
Zarate CA; Brutsche N; Laje G; Luckenbaugh DA; Venkata SL; Ramamoorthy A; Moaddel R; Wainer IW
Biol Psychiatry; 2012 Aug; 72(4):331-8. PubMed ID: 22516044
[TBL] [Abstract][Full Text] [Related]
5. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
6. Do the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh DA; Niciu MJ; Ionescu DF; Nolan NM; Richards EM; Brutsche NE; Guevara S; Zarate CA
J Affect Disord; 2014 Apr; 159():56-61. PubMed ID: 24679390
[TBL] [Abstract][Full Text] [Related]
7. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
[TBL] [Abstract][Full Text] [Related]
8. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
[TBL] [Abstract][Full Text] [Related]
9. The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.
Mathai DS; Meyer MJ; Storch EA; Kosten TR
J Affect Disord; 2020 Mar; 264():123-129. PubMed ID: 32056741
[TBL] [Abstract][Full Text] [Related]
10. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
11. [Ketamine's antidepressant effect: literature review on clinical use].
De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
Encephale; 2014 Feb; 40(1):15-23. PubMed ID: 24434008
[TBL] [Abstract][Full Text] [Related]
12. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
Xu AJ; Niciu MJ; Lundin NB; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Machado-Vieira R; Zarate CA
Neural Plast; 2015; 2015():858251. PubMed ID: 26137324
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction.
Bonnet U
J Psychoactive Drugs; 2015; 47(4):276-85. PubMed ID: 26317449
[TBL] [Abstract][Full Text] [Related]
14. Ketamine for Depression, 2: Diagnostic and Contextual Indications.
Andrade C
J Clin Psychiatry; 2017 May; 78(5):e555-e558. PubMed ID: 28570803
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population.
Shiroma PR; Velit-Salazar MR; Vorobyov Y
Clin Drug Investig; 2022 Jul; 42(7):549-566. PubMed ID: 35672558
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression.
Acevedo-Diaz EE; Cavanaugh GW; Greenstein D; Kraus C; Kadriu B; Zarate CA; Park LT
J Affect Disord; 2020 Feb; 263():568-575. PubMed ID: 31791675
[TBL] [Abstract][Full Text] [Related]
17. Rapid antidepressant effect of S-ketamine in schizophrenia.
Bartova L; Papageorgiou K; Milenkovic I; Dold M; Weidenauer A; Willeit M; Winkler D; Kasper S
Eur Neuropsychopharmacol; 2018 Aug; 28(8):980-982. PubMed ID: 30041987
[TBL] [Abstract][Full Text] [Related]
18. Ketamine Treatment for Depression in Patients With a History of Psychosis or Current Psychotic Symptoms: A Systematic Review.
Veraart JKE; Smith-Apeldoorn SY; Spijker J; Kamphuis J; Schoevers RA
J Clin Psychiatry; 2021 Jul; 82(4):. PubMed ID: 34255943
[No Abstract] [Full Text] [Related]
19. Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review.
Veraart JKE; Smith-Apeldoorn SY; Bakker IM; Visser BAE; Kamphuis J; Schoevers RA; Touw DJ
Int J Neuropsychopharmacol; 2021 Oct; 24(10):808-831. PubMed ID: 34170315
[TBL] [Abstract][Full Text] [Related]
20. Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties.
Duncan WC; Slonena E; Hejazi NS; Brutsche N; Yu KC; Park L; Ballard ED; Zarate CA
Biol Psychiatry; 2017 Sep; 82(5):361-369. PubMed ID: 28457485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
